Melanoma Research Foundation · MRF 261794-01
Developing therapies that mimic caloric restriction for melanoma control
NCNicholas Collins
2026–2028
Breast Cancer Research Foundation, Inc. · BCRF-26-154
Dietary and Pharmacologic Interventions to Optimize Weight in Individuals with Breast Cancer
NCNicholas Collins
2026–2028
Charles H. Revson Foundation Inc. · 26-34 (BWF 1058676)
A novel T cell vaccine candidate: Leveraging antigen cross-presentation pathways to generate cross-reactive pan-Coronavirus specific CD8 T cells
JMJulie Magarian Blander
2026–2029
Sanofi S.A. · BP 265072-01
TL1A-Induced GM-CSF Shapes Innate Immune Memory Linking Colitis with Systemic Inflammatory Tone
RLRandy Longman
2026–2029
National Institute of Allergy & Infectious Diseases · 1 U01 AI201051-01
Novel innate lymphocyte pathways controlling mucosal immunity
GFGregory Field Sonnenberg
2026–2031
National Cancer Institute · 1 R01 CA311885-01
Caloric restriction to enhance cancer immunoprevention
NCNicholas CollinsDADavid Artis
2026–2031
Crohn's & Colitis Foundation of America, Inc. · CCFA 1616748
Assessing immunomodulation of VE202 live biotherapeutic product in UC
RLRandy Longman
2026–2027
Crohn's & Colitis Foundation of America, Inc. · CCFA 1715651
6th Annual NYC IBD Research Day
GFGregory Field Sonnenberg
2026–2027
National Institute of Diabetes & Digestive & Kidney Diseases · 1 K99 DK147794-01
Adaptive Immune Regulation of Enteric Neurogenesis Directs Intestinal Inflammation
DADavid Artis
2026–2028
National Institute of Allergy & Infectious Diseases · 1 R01 AI198729-01
Immune mechanisms of fungal influence on the gut-brain axis.
IDIliyan D Iliev
2026–2031
Melanoma Research Alliance · 1584423
Targeting the melanoma metabolic microenvironment to boost T-cell therapy
NCNicholas Collins
2026–2029
National Cancer Institute · 1 R01 CA306020-01A1
Identifying targets to mitigate immunotherapy-associated immune-related adverse events
NCNicholas Collins
2026–2031
Crohn's & Colitis Foundation of America, Inc. · CCFA 1455095
Innate sensing of inflammatory cell death in the intestinal epithelium
JMJulie Magarian Blander
2025–2028
Crohn's & Colitis Foundation of America, Inc. · 1447818
Colitis drive tumor promoting neutrophils and shapes bone marrow progenitors.
RLRandy Longman
2025–2028
Kenneth Rainin Foundation · KRF 20250291
Distinct Adaptive Repair Responses to Cell Death Modes in the Intestinal Epithelium
JMJulie Magarian Blander
2025–2026
National Institute of Diabetes & Digestive & Kidney Diseases · 1 K08 DK144639-01
Defining novel neuro-immune pathways that regulate gut physiology
GFGregory Field Sonnenberg
2025–2030
National Institute on Aging · 5 R00 AG076987-04
Understanding the role of the stromal cell niche in intestinal stem cell aging
NGNorihiro Goto
2025–2028
National Institute of Diabetes & Digestive & Kidney Diseases · 2 T32 DK116970-06A1
Multidisciplinary Research Training in Gastroenterology and Hepatology
RLRandy Longman
2025–2030
National Institute of Allergy & Infectious Diseases · 2 R01 AI145989-06
Cytokine regulation of mucosal inflammation
GFGregory Field Sonnenberg
2025–2029
National Institute of Diabetes & Digestive & Kidney Diseases · 5 R01 DK120985-06
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
RLRandy Longman
2025–2029

Jill Roberts Institute for Research in Inflammatory Bowel Disease

Transferable genetic toolsets for nonmodel gut Clostridia enable in vivo reversible control of metabolite production

Caspase 5c amplifies Wnt via APC cleavage to promote intestinal homeostasis

ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut